- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04136639
The Anticariogenic Effect of Miswak (Silvadora Persica) and Grape Seed Extract
October 21, 2019 updated by: Hala Ahmed Abdel Moneim, Al-Azhar University
Prevention of dental caries has taken a great importance in the last decade.
The use of herbal and natural products became mandatory to avoid the side effects of commercially available medications.
Aim of the study; the aim was to investigate the anti-cariogenic effect of miswak and grape seed extract (GSE).
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Patients used Miswak sticks, grape seed extract mouth wash and fluoride mouthwash twice daily for three month.
Saliva samples were collected at base line and after one month and three month.
Assessment of bacterial count and saliva buffering capacity were performed at base line and after one and three month.
Study Type
Interventional
Enrollment (Actual)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Nasr City
-
Cairo, Nasr City, Egypt
- Al Azhar University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 50 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients with high caries risk
- Males or females
- Medically free patients
- Patients approving to participate in the study
Exclusion Criteria:
- Patients who were on antibiotic therapy or corticosteroid therapy for 30 days before the examination
- Patients had history of professional cleaning in the last 15 days
- Patients with exposed pulp
- Evidence of parafunctional habits
- Patients with developmental dental anomalies
- Patients undergoing or will start orthodontic treatment
- Patients with removable prosthesis
- Periapical Abscess or Fistula
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Miswak
Miswak sticks used twice daily, every 12 hours, for three months.
|
sticks
Other Names:
|
|
Experimental: Grape Seed Extract
Grape seed extract 6.5% mouthwash used twice daily, every 12 hours, for three months.
|
Mouthwash
Other Names:
|
|
Active Comparator: Fluoride Mouthwash
0.05% fluoride mouthwash used twice daily, every 12 hours, for three months.
|
mouthwash
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
quantitative measure of the change in salivary streptococcus mutans Count from baseline to one month and three months.
Time Frame: Baseline, one month, three months.
|
the patients used the treatments twice daily for three months.
unstimulated saliva samples were collected from the patients at baseline,after one month and after three months.
Every time samples were incubated with Mitiis Salivaris with Bacitricin and 20% sucrose for streptococcus mutans count.
|
Baseline, one month, three months.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
quantitative measure of the change in saliva buffering capacity from baseline to one month and three months.
Time Frame: baseline, one month , three months
|
the patients used the treatments twice daily for three months.
unstimulated saliva samples were collected from the patients at baseline, after one month and after three months.
each time, saliva buffering capacity was measured using Hand Held pH meter and 0.1 mol/l hydrochloric acid that was titrated to the tested saliva.
|
baseline, one month , three months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Maha Niazy, professor, Al-Azhar University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2019
Primary Completion (Actual)
August 31, 2019
Study Completion (Actual)
October 1, 2019
Study Registration Dates
First Submitted
October 19, 2019
First Submitted That Met QC Criteria
October 21, 2019
First Posted (Actual)
October 23, 2019
Study Record Updates
Last Update Posted (Actual)
October 23, 2019
Last Update Submitted That Met QC Criteria
October 21, 2019
Last Verified
October 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Stomatognathic Diseases
- Tooth Demineralization
- Tooth Diseases
- Dental Caries
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Anti-Infective Agents
- Antineoplastic Agents
- Protective Agents
- Antineoplastic Agents, Phytogenic
- Antiprotozoal Agents
- Antiparasitic Agents
- Antioxidants
- Cariostatic Agents
- Fluorides
- Sodium Fluoride
- Proanthocyanidin
- Grape Seed Extract
Other Study ID Numbers
- REC17-082
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dental Caries
-
National University of San Marcos, PeruNot yet recruitingPit and Fissure Caries | Caries,Dental | Sealant DentalPeru
-
Ain Shams UniversityCompletedPulpitis | Caries | Caries,Dental | Reversible Pulpitis | Caries Class I | Caries; DentinEgypt
-
University of MinnesotaCompletedUsing Motivational Interviewing To Reduce Parental Risk-Related Behaviors For Early Childhood CariesCaries | Caries,DentalUnited States
-
Future University in EgyptNot yet recruitingDeep Caries | Caries, Dental
-
Federal University of PelotasRecruiting
-
Kompetansesenteret Tannhelse Midt (TkMidt)Karolinska Institutet; University of Bergen; Norwegian University of Science... and other collaboratorsActive, not recruiting
-
Marmara UniversityCompleted
-
Suez Canal UniversityCompleted
-
Pomeranian Medical University SzczecinCompleted
-
Universidad Autonoma de Baja CaliforniaNot yet recruitingDental Caries in Children | Caries, Dental | Caries; DentinMexico
Clinical Trials on Miswak
-
Kuwait UniversityCompletedPeriodontitis | CariesKuwait
-
King Saud Bin Abdulaziz University for Health SciencesKuwait UniversityCompleted
-
King Abdulaziz UniversityCompletedDental Caries | Dental Plaque AccumulationSaudi Arabia
-
King Abdulaziz UniversityNot yet recruiting
-
Riyadh Colleges of Dentistry and PharmacyCompleted
-
Al-Hawash Private UniversityRecruitingDental Plaque | Orthodontic PatientsSyria
-
Ministry of Health, Saudi ArabiaUnknown
-
Cairo UniversityUnknown
-
Ajman UniversityCompletedGingivitis | Plaque, DentalUnited Arab Emirates
-
Riyadh Elm UniversityCompleted